An incidental nding of severe hyperferritinaemia: a lesson to be learned Haemophagocytic lymphohistiocytosis is a rare, under-recognised and often misdiagnosed condition, characterised by a hyperin ammatory response to malignancy or infection. In this case, the cause was a bone marrow isolated anaplastic large cell lymphoma without radiological evidence of systemic disease, a phenomenon rarely described.
Over the following month, she was referred twice to hospital with progression of symptoms and new pleuritic chest pain. Laboratory workup was normal except ferritin was again raised to 3207 ug/L, and D-dimer to 4500 ug/L. Computed tomography (CT) pulmonary angiogram excluded a pulmonary embolism and there was no evidence of mediastinal lymphadenopathy. She was discharged with a diagnosis of a viral illness. On the second admission, CT sinus and head demonstrated sinusitis. She was given a further course of oral antibiotics and started on prednisolone.
Eight days later she returned to hospital with high fever, rigors, night sweats and headaches. She appeared systemically unwell with a fever of 40.7°C, tachycardia, hypotension, tachypnoea, and hypoxia; examination revealed no palpable lymphadenopathy or organomegaly.
Her blood tests were haemoglobin 111 g/L, platelets 78, white cell count 3.4, neutrophils 2.3, lymphocytes 0.3, activated partial thromboplastin time 64 s, prothrombin ratio 1.6, fi brinogen 0.4 g/L, lactate dehydrogenase 2483 U/L, beta-2 microglobulin 9.2 mg/L, ferritin > 50,000 ug/L, gammaglutamyl transpeptidase 250 U/L, alkaline phosphatase 383 U/L, and alanine aminotransferase 710 U/L.
The diagnosis of haemophagocytic lymphohistiocytosis (HLH) was suspected and therefore high dose dexamethasone was started and a bone marrow biopsy obtained.The aspirate demonstrated a pleomorphic population of atypical large lymphoid cells along with haemophagocytosis ( Figure 1 ). Concerns about aggressive lymphoma triggered a request for a full body staging CT. This showed a psoas muscle haematoma, possibly from bone marrow biopsy in the context of coagulopathy, but there were no other abnormalities. Fibrinogen-rich cryoprecipitate Unfortunately, the patient deteriorated with progressive multiorgan failure. Her care was escalated but despite maximum intensive care support she passed away with her family present, just 5 days after admission.
The bone marrow trephine ( Figure 2 ) results subsequently became available; interstitial infiltrates of pleomorphic mononuclear T cells of anaplastic morphology were confi rmed on immunohistochemistry (Figure 3 ). These cells were positive for CD45, CD3, CD30 and EMA, but negative for CD15, granzyme B, TIA-1, EBER and ALK-1. The fi nding of activated macrophages phagocytosing haematological elements was prominent. Post mortem examination confi rmed the clinical diagnosis of multi-organ failure caused by HLH, triggered by ALK negative anaplastic large cell lymphoma. Marrow, adrenal, liver and spleen infiltration was demonstrated histologically but not radiologically.
Discussion
HLH is a rare and potentially fatal clinical syndrome characterised by unchecked immunological activation. 1 The diagnosis relies on identifying a genetic mutation associated with primary HLH or, as in this case, satisfying at least fi ve of eight criteria required in secondary HLH (Table 1) . 1 The diffi culty in meeting the diagnostic criteria in the early stages of disease, its rarity and variable clinical presentation, leads to under-, near-missed and missed diagnosis.
While there is no single disease specifi c marker for HLH, severe hyperferritinaemia as defi ned by ferritin > 10,000 can be a useful marker of phagocytosis. 2 A large study in a Texas children's hospital demonstrated that this level is 90% sensitive and 96% specifi c for HLH. 2 The specifi city in adults is not known; a study of 113 hospitalised patients from a large academic centre showed levels > 50,000 were also observed in renal failure, hepatocellular injury and haematological malignancy. 3 In our case the patient was well with no signifi cant medical history. We therefore support the argument that ferritin specifi city for HLH is maintained in the well adult presenting with undifferentiated illness.
Bone marrow biopsy is an important investigative tool in HLH as haemophagocytosis is one of the diagnostic criteria and assists in identifying the underlying cause. It is important to note that early in the HLH presentation, a bone marrow biopsy may not show haemophagocytosis and therefore it is important to repeat if clinical suspicion remains high. 4 HLH can be inherited; however, acquired forms secondary to autoimmune and metabolic conditions, infections (mostly viral) or haematological malignancies, as in this case, are more common. 4 Malignancies are characterised by T cell immunosuppression, as in T cell lymphomas, NK cell leukaemia and EBV driven T cell and B cell lymphomas. 4 If secondary HLH is suspected, a rapid search for the underlying cause is vital, as treating this simultaneously is required to achieve remission. 5 In this case HLH was the sole manifestation of malignant T cell lymphoma. The lymphoma was occult clinically and radiologically as there was no nodal enlargement or hepatosplenomegaly detected on repeated imaging. Had a bone marrow biopsy been performed earlier, the rare entity of primary anaplastic large cell lymphoma of the marrow may have been found. 6, 7 Commencing etoposide treatment at that early stage may have improved the outcome. 8 This case demonstrates the diffi culty in diagnosing HLH and the usefulness in performing ferritin assay in the febrile patient with an undifferentiated presentation. It underscores the importance of early collection of a bone marrow biopsy in the setting of unexplained hyperferritinaemia > 10,000 and fi nally highlights the high mortality risk if diagnosis is delayed until multi-organ involvement occurs and ferritin reaches exceptionally high levels (> 50,000). 
